Abstract
Background: There are no published guidelines for the pharmacological management of insomnia in the pediatric population, and there are no Food and Drug Administration (FDA) approved medications for this purpose. Yet, many classes of psychopharmacological medications are used off-label in children and adolescents.
Objective: To describe the side effects of different classes of medications used as sleep aids in the pediatric population, and management of those side effects.
Method: Literature review and summary of existing evidence.
Results: Several medications used as pediatric sleep aids have side effects that range from inconvenient constitutional symptoms, major systemic cardiac, endocrinological and neurological symptoms to potentially fatal syndromes.
Conclusion: Clinicians need to be vigilant for adverse effects of these medications and to implement strategies to mitigate some of the effects, while educating patients and families about the pros and cons of medication use for insomnia.
Keywords: Insomnia, children and adolescents, psychopharmacology, side effects, medications, endocrinological and neurological symptoms.
Current Psychopharmacology
Title:Management of Adverse Effects of Sleep Medications in Pediatrics
Volume: 7
Author(s): Neelkamal Soares*Shibani Kanungo
Affiliation:
- Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker School of Medicine, Kalamazoo, MI, 49008,United States
Keywords: Insomnia, children and adolescents, psychopharmacology, side effects, medications, endocrinological and neurological symptoms.
Abstract: Background: There are no published guidelines for the pharmacological management of insomnia in the pediatric population, and there are no Food and Drug Administration (FDA) approved medications for this purpose. Yet, many classes of psychopharmacological medications are used off-label in children and adolescents.
Objective: To describe the side effects of different classes of medications used as sleep aids in the pediatric population, and management of those side effects.
Method: Literature review and summary of existing evidence.
Results: Several medications used as pediatric sleep aids have side effects that range from inconvenient constitutional symptoms, major systemic cardiac, endocrinological and neurological symptoms to potentially fatal syndromes.
Conclusion: Clinicians need to be vigilant for adverse effects of these medications and to implement strategies to mitigate some of the effects, while educating patients and families about the pros and cons of medication use for insomnia.
Export Options
About this article
Cite this article as:
Soares Neelkamal *, Kanungo Shibani , Management of Adverse Effects of Sleep Medications in Pediatrics, Current Psychopharmacology 2018; 7 (1) . https://dx.doi.org/10.2174/2211556007666180131153440
DOI https://dx.doi.org/10.2174/2211556007666180131153440 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cognitive Identity in Schizophrenia: Vision, Space, and Body Perception from Prodrome to Syndrome
Current Psychiatry Reviews Pharmacogenomics in Drug Induced Liver Injury
Current Drug Metabolism Computational Approaches for Translational Oncology: Concepts and Patents
Recent Patents on Anti-Cancer Drug Discovery Ion Channels and Epilepsy
Current Pharmaceutical Design Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin
Drug Delivery Letters Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems
Current Drug Targets Restless Leg Syndrome Associated with Atypical Antipsychotics: Current Status, Pathophysiology, and Clinical Implications
Current Drug Safety Structural Biology of Bacterial Iron Uptake Systems
Current Topics in Medicinal Chemistry The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Current Molecular Medicine Clinical Application of the Vestibular Stimulation Effect on Balance Disorders with Dementia
Current Alzheimer Research Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Current Neuropharmacology An Overview of Acute Flaccid Myelitis
CNS & Neurological Disorders - Drug Targets Quantitative Analysis of Microbial Metabolism in the Human Large Intestine
Current Nutrition & Food Science Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
Current Pharmaceutical Design Conference Report: 184th American Association for the Advancement of Science Annual Meeting, Austin TX, USA Feb. 15-19, 2018
CNS & Neurological Disorders - Drug Targets A Review Study on Prakriti (Body Constitution) Specific Herbal Tea in Diabetes Mellitus
Current Traditional Medicine Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran
Infectious Disorders - Drug Targets Assessment of Motor Function in Complex Regional Pain Syndrome With Virtual Reality-based Mirror Visual Feedback: A Pilot Case Study
Neuroscience and Biomedical Engineering (Discontinued)